SCHEDULE: Inmune Bio: Praetorian & Mongolia Group Disclose Holdings
Ownership Disclosure
Multiple investment entities and individuals, including Praetorian Capital and Mongolia Growth Group, have disclosed their beneficial ownership in Inmune Bio, Inc., totaling up to 3.4% of outstanding shares.
Summary
- Praetorian Capital Fund LLC, Praetorian PR LLC, and Praetorian Capital Management LLC collectively reported beneficial ownership of 771,200 shares of Inmune Bio, Inc. common stock, representing approximately 2.9% of the outstanding class.
- This ownership includes 180,800 shares issuable upon warrant exercise and 590,400 shares underlying call options, all exercisable within 60 days of June 30, 2025.
- Mongolia (Barbados) Corp. and Mongolia Growth Group Ltd. disclosed beneficial ownership of 150,000 shares, representing approximately 0.6% of the outstanding class, consisting of shares underlying call options exercisable within 60 days of June 30, 2025.
- Harris Kupperman, through his roles at Praetorian entities and Mongolia Growth Group, is deemed to beneficially own an aggregate of 921,200 shares, representing approximately 3.4% of the outstanding class.
- The percentages are based on 26,585,258 shares outstanding as of June 30, 2025, plus shares underlying exercisable warrants.
Sentiment
Score: 5
Explanation: The filing is a standard beneficial ownership disclosure (Schedule 13G) and does not contain information that would inherently indicate positive or negative sentiment regarding the company's performance or prospects. It merely reports the ownership stakes of certain entities and individuals.
Positives
- Increased transparency regarding significant shareholder positions.
- Indicates continued interest from investment groups in Inmune Bio.
Risks
- No specific risks related to Inmune Bio's operations or financial health are mentioned in this ownership disclosure.
- The filing states that the securities were not acquired or held for the purpose of changing or influencing control of the issuer, other than activities solely in connection with a nomination under Rule 14a-11, which could imply potential future proxy activity.
Future Outlook
NA
Industry Context
NA
Related Party Transactions
- Praetorian PR LLC serves as the investment manager of Praetorian Capital Fund LLC.
- Praetorian Capital Management LLC serves as the manager of Praetorian Capital Fund LLC.
- Mongolia Growth Group Ltd. is the controlling person and sole shareholder of Mongolia (Barbados) Corp.
- Harris Kupperman is the managing member of Praetorian PR LLC and Praetorian Capital Management LLC, and the CEO and Executive Chairman of Mongolia Growth Group Ltd., linking all reporting entities.
Stakeholder Impact
- Shareholders: Provides transparency on significant ownership stakes by institutional and individual investors, which can influence market perception and trading activity.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event requiring the filing of this statement and the effective date for beneficial ownership calculations. |
| 08/14/2025 | Date of filing and signature date for the Schedule 13G Amendment No. 2. |
Keywords
Inmune Bio, INMB, Schedule 13G, beneficial ownership, Praetorian Capital, Mongolia Growth Group, Harris Kupperman, common stock, SEC filing, investment disclosure
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.